HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ørbo, Anne, Arnes, Marit, Lyså, Lena Myreng, Borgfeldt, Christer, Straume, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117800/
https://www.ncbi.nlm.nih.gov/pubmed/27711084
http://dx.doi.org/10.1038/bjc.2016.330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117800/
https://www.ncbi.nlm.nih.gov/pubmed/27711084
http://dx.doi.org/10.1038/bjc.2016.330

Ejemplares similares